Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.
In Silico & Data InsightsRegulatory SubmissionStudy Management
With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.
NAMs have the potential to deliver more efficient safety assessments, enabling faster and more confident development decisions while also supporting more ethical drug development.
Compliance Builder 12 introduces several enhancements that directly support stronger compliance control and faster issue detection, helping organizations prevent minor issues from becoming major CAPA violations.
We are excited to announce the revival of the d-wise brand to represent Instem’s Clinical Trial Analytics and Transparency offerings. This movement returns our clinical portfolio to its roots while reinforcing our dedication to supporting...
Whether you need a small-scale LIMS option, support for the stability study lifecycle, or tools to optimize client interactions, our LIMS solution provides these capabilities in a future-proof, user-friendly package.
Lab ExecutionMatrix GeminiRegulatory ComplianceStudy Planning and Execution
If you’re looking to enhance efficiency, strengthen data integrity, or modernize your veterinary diagnostic workflows, Matrix Gemini LIMS offers a future-proof solution that supports both current needs and long-term growth.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.